Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein - PubMed (original) (raw)
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein
Benoit I Giasson et al. Neuron. 2002.
Free article
Abstract
alpha-Synucleinopathies are neurodegenerative disorders that range pathologically from the demise of select groups of nuclei to pervasive degeneration throughout the neuraxis. Although mounting evidence suggests that alpha-synuclein lesions lead to neurodegeneration, this remains controversial. To explore this issue, we generated transgenic mice expressing wild-type and A53T human alpha-synuclein in CNS neurons. Mice expressing mutant, but not wild-type, alpha-synuclein developed a severe and complex motor impairment leading to paralysis and death. These animals developed age-dependent intracytoplasmic neuronal alpha-synuclein inclusions paralleling disease onset, and the alpha-synuclein inclusions recapitulated features of human counterparts. Moreover, immunoelectron microscopy revealed that the alpha-synuclein inclusions contained 10-16 nm wide fibrils similar to human pathological inclusions. These mice demonstrate that A53T alpha-synuclein leads to the formation of toxic filamentous alpha-synuclein neuronal inclusions that cause neurodegeneration.
Similar articles
- Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Cabin DE, Gispert-Sanchez S, Murphy D, Auburger G, Myers RR, Nussbaum RL. Cabin DE, et al. Neurobiol Aging. 2005 Jan;26(1):25-35. doi: 10.1016/j.neurobiolaging.2004.02.026. Neurobiol Aging. 2005. PMID: 15585343 - Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.
Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Masliah E, et al. Science. 2000 Feb 18;287(5456):1265-9. doi: 10.1126/science.287.5456.1265. Science. 2000. PMID: 10678833 - Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, Trojanowski JQ, Lee VM. Yazawa I, et al. Neuron. 2005 Mar 24;45(6):847-59. doi: 10.1016/j.neuron.2005.01.032. Neuron. 2005. PMID: 15797547 - Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M. Goedert M. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review. - Neuropathological spectrum of synucleinopathies.
Jellinger KA. Jellinger KA. Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
Cited by
- α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model.
So RWL, Amano G, Stuart E, Ebrahim Amini A, Aguzzi A, Collingridge GL, Watts JC. So RWL, et al. PLoS Pathog. 2024 Sep 12;20(9):e1012517. doi: 10.1371/journal.ppat.1012517. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39264912 Free PMC article. - Involvement of KV3.4 Channel in Parkinson's Disease: A Key Player in the Control of Midbrain and Striatum Differential Vulnerability during Disease Progression?
Magliocca G, Esposito E, Tufano M, Piccialli I, Rubino V, Tedeschi V, Sisalli MJ, Carriero F, Ruggiero G, Secondo A, Annunziato L, Scorziello A, Pannaccione A. Magliocca G, et al. Antioxidants (Basel). 2024 Aug 18;13(8):999. doi: 10.3390/antiox13080999. Antioxidants (Basel). 2024. PMID: 39199246 Free PMC article. - A dual target molecular magnetic resonance imaging probe for noninvasive profiling of pathologic alpha-synuclein and microgliosis in a mouse model of Parkinson's disease.
Sun X, Badachhape A, Bhandari P, Chin J, Annapragada A, Tanifum E. Sun X, et al. Front Neurosci. 2024 Jul 24;18:1428736. doi: 10.3389/fnins.2024.1428736. eCollection 2024. Front Neurosci. 2024. PMID: 39114484 Free PMC article. - Cognitive dysfunction in animal models of human lewy-body dementia.
Haikal C, Winston GM, Kaplitt MG. Haikal C, et al. Front Aging Neurosci. 2024 Jul 22;16:1369733. doi: 10.3389/fnagi.2024.1369733. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39104707 Free PMC article. Review. - Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers.
Nielsen J, Lauritsen J, Pedersen JN, Nowak JS, Bendtsen MK, Kleijwegt G, Lusser K, Pitarch LC, Moreno JV, Schneider MM, Krainer G, Goksøyr L, Khalifé P, Kaalund SS, Aznar S, Kjærgaard M, Sereikaité V, Strømgaard K, Knowles TPJ, Nielsen MA, Sander AF, Romero-Ramos M, Otzen DE. Nielsen J, et al. NPJ Parkinsons Dis. 2024 Jul 29;10(1):139. doi: 10.1038/s41531-024-00747-6. NPJ Parkinsons Dis. 2024. PMID: 39075088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous